
According to the South Korean team, doctors in China are interested in a partnership and learning more about an experimental drug that it has developed to combat the disease.
The team’s study, titled “Oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death in ischemic stroke,” was published online last week in the journal Cell Metabolism.
Advertisement
Ischemic stroke occurs when a blood clot or other blockage obstructs a cerebral blood vessel, cutting off oxygen and nutrients and causing brain cells to die.
Advertisement
Survivors often suffer severe aftereffects, including motor disabilities and cognitive decline. Treatment is further complicated by a narrow three-hour “golden time” window after symptom onset, during which patients must receive emergency care.

Don't Miss:
-
Two Years On, the Sinaloa Cartel War Changes Shape | The InSight Take
-
US wraps up military mission in Iraq, giving Baghdad room to strengthen China ties
-
As China and the EU begin crunch trade talks, optimism is in short supply
-
Data centre opposition is growing in Australia. Is there a middle ground?
-
Helper arrested for allegedly slapping 5-year-old boy after he refuses to eat

Prabowo Faces Growing Discontent as Jokowi Revives His Political Ambitions
Five years after the Pandora Papers, transparency laws lose their teeth
How Hungary’s richest man funneled millions into Orbán’s propaganda machine